KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gsk (GSK) FCF Payout Ratio (2016 - 2025)

Historic FCF Payout Ratio for Gsk (GSK) over the last 17 years, with Q4 2025 value amounting to 0.2.

  • Gsk's FCF Payout Ratio rose 4601.03% to 0.2 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.25, marking a year-over-year decrease of 767.18%. This contributed to the annual value of 0.25 for FY2025, which is 560.04% up from last year.
  • Per Gsk's latest filing, its FCF Payout Ratio stood at 0.2 for Q4 2025, which was up 4601.03% from 0.23 recorded in Q3 2025.
  • Over the past 5 years, Gsk's FCF Payout Ratio peaked at 0.02 during Q3 2023, and registered a low of 1.38 during Q1 2021.
  • Over the past 5 years, Gsk's median FCF Payout Ratio value was 0.24 (recorded in 2025), while the average stood at 0.35.
  • Per our database at Business Quant, Gsk's FCF Payout Ratio plummeted by 117001.06% in 2022 and then skyrocketed by 8773.48% in 2023.
  • Gsk's FCF Payout Ratio (Quarter) stood at 0.09 in 2021, then plummeted by 689.08% to 0.73 in 2022, then skyrocketed by 37.72% to 0.46 in 2023, then rose by 19.65% to 0.37 in 2024, then soared by 46.01% to 0.2 in 2025.
  • Its last three reported values are 0.2 in Q4 2025, 0.23 for Q3 2025, and 0.24 during Q2 2025.